Coimbra IPO recognized internationally in oncology and palliative care

The Portuguese Institute of Oncology of Coimbra has been distinguished by the European Society for Medical Oncology for its integration of care.

Generic image of a medical symbol representing integrated oncology and palliative care.
AI

Generic image of a medical symbol representing integrated oncology and palliative care.

The Portuguese Institute of Oncology of Coimbra Francisco Gentil has been recognized by the European Society for Medical Oncology (ESMO) as an “ESMO Designated Centre of Integrated Oncology and Palliative Care” for the period 2027–2029.

The recognition highlights the integration between oncological care and palliative care, promoting continuity of care, support for patients and their families, training, and research. The IPO of Coimbra joins an international network of over 260 accredited centers in 58 countries.
In a statement, the IPO of Coimbra expressed pride in the achievement, valuing the work of the professionals involved in the patient's journey within the institution. The distinction also reinforces the institutional commitment to a person-centered approach, linking disease treatment with attention to needs and quality of life.
Based on information from the official source: SNS - Serviço Nacional de Saúde (26/10/2026)